Stefanie Cavanaugh - 04 Jun 2025 Form 4 Insider Report for Aspira Women's Health Inc. (AWHL)

Role
Director
Signature
/s/ Stefanie Cavanaugh
Issuer symbol
AWHL
Transactions as of
04 Jun 2025
Net transactions value
$0
Form type
4
Filing time
05 Jun 2025, 16:15:43 UTC
Previous filing
01 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cavanaugh Stefanie L. Director C/O ASPIRA WOMEN'S HEALTH INC, 12117 BEE CAVES RD, BLDG 3-100, AUSTIN, /s/ Stefanie Cavanaugh 05 Jun 2025 0001688530

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AWHL Common Stock Options Exercise $0 +5,937 +8.2% $0.000000 78,726 04 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AWHL Restricted Stock Units Options Exercise $0 -5,937 -100% $0.000000 0 04 Jun 2025 Common Stock 5,937 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Stefanie Cavanaugh is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
F2 Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock
F3 On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.